
SF Healthcare Week: Baird Senior Analyst Brian Skorney comments on Monday's conference news and highlights his top picks ahead for 2026
BiotechTV - News
00:00
Azetocolinum's Seizure Efficacy Profile
Brian describes strong seizure reductions, durable seizure‑free periods, and favorable tolerability versus other ASMs.
Play episode from 04:09
Transcript


